サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563832

不妊治療サービスの世界市場

Fertility Services

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
不妊治療サービスの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

不妊治療サービスの世界市場は2030年までに1,242億米ドルに到達

2023年に470億米ドルと推定される不妊治療サービスの世界市場は、2030年には1,242億米ドルに達し、分析期間2023-2030年のCAGRは14.9%で成長すると予測されます。本レポートで分析したセグメントの1つである生鮮非ドナーサービスは、CAGR16.1%を記録し、分析期間終了時には753億米ドルに達すると予測されます。冷凍非ドナーサービス分野の成長率は、分析期間中CAGR13.7％と推定されます。

米国市場は推定121億米ドル、中国はCAGR19.3％で成長予測

米国の不妊治療サービス市場は2023年に121億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに317億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは19.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.2%と12.6%と予測されています。欧州では、ドイツがCAGR 11.4%で成長すると予測されています。

世界の不妊治療サービス市場- 主要動向と促進要因のまとめ

不妊治療サービスはリプロダクティブヘルスと家族計画にどのような革命をもたらしているのか？

不妊治療サービスは、妊娠の課題に直面している個人やカップルに高度な医療介入と個別ケアを提供することで、生殖医療と家族計画を変革しています。不妊治療に対する認識と受容が高まる中、体外受精（IVF）、卵子凍結、遺伝子スクリーニングなどの生殖補助医療技術（ART）の進歩は、世界中の何百万人もの人々に希望を与えています。不妊治療サービスには、不妊症の診断や治療、家族計画のサポート、生殖機能の改善などに役立つさまざまな治療が含まれています。これらのサービスは、現代のヘルスケアにおいて不可欠なものとなりつつあり、年齢や病状、その他の要因にもかかわらず、個人やカップルが親になるという夢を実現することを可能にしています。

近年、出産の遅れ、ライフスタイルの変化、不妊率の上昇などの社会的な変化により、不妊治療サービスに対する需要が高まっています。不妊治療専門クリニックでは、不妊判定やホルモン治療から最先端のART治療まで、幅広いサービスを提供しています。特に、将来の妊娠のために生殖能力を維持したいと願う女性の間で、卵子凍結の増加が大きな動向となっています。このような不妊治療サービスの拡大は、個人が生殖に関する健康をコントロールする力を与えるだけでなく、特に同性カップルや片親、生殖に関する健康課題に直面している人々にとって、家族計画をより身近で包括的なものにしています。不妊治療が進歩し、社会的に受け入れられるようになるにつれ、こうしたサービスは、人々がどのように家族計画を立てるかにおいて、変革的な役割を果たしています。

なぜ不妊治療サービスは、生殖に関する課題に取り組み、家族計画の選択肢を広げるために重要なのでしょうか？

不妊治療サービスは、自然妊娠の障害に直面している個人やカップルに医学的な解決策を提供するため、生殖の課題に対処し、家族計画の選択肢を広げるために重要です。世界的に約10～15％のカップルに影響を及ぼしている不妊症の有病率が増加する中、不妊治療サービスは妊娠を妨げる基礎疾患を診断・治療することで、希望とサポートを提供します。年齢、ホルモンバランスの乱れ、遺伝的要因、生活習慣の問題など、不妊症は精神的にも肉体的にも負担のかかるものです。体外受精（IVF）、子宮内人工授精（IUI）、卵子や精子の提供などの不妊治療により、これらの障害を克服し、妊娠を成功させることができます。

不妊治療サービスはまた、不妊に直面していなくても、家族計画のための代替手段を求めている人々に選択肢を提供する上で極めて重要です。個人的な理由やキャリア上の理由で出産を遅らせることを選択した女性は、卵子凍結に頼ることができるようになりました。さらに、不妊治療サービスは、LGBTQ+の個人やカップル、また、家族を作るために卵子提供や精子提供、代理出産を必要とするひとり親にも、重要な選択肢を提供しています。これらのサービスは、親になることが生物学的な制約や伝統的な家族構成によって制限されないことを保証し、子どもを持つためのより包括的で多様な道を提供します。

不妊治療サービスのもうひとつの重要な役割は、多嚢胞性卵巣症候群（PCOS）、子宮内膜症、精子の数や運動率の低下といった男性不妊症といった医学的な症状への対応です。不妊治療クリニックでは、妊娠の可能性を高めるための治療や介入を行っています。さらに、遺伝子スクリーニングや着床前遺伝学的検査（PGT）の進歩により、妊娠前に遺伝子疾患を特定することが可能になり、両親と赤ちゃんの両方により健康的な結果をもたらすことができます。このような不妊治療への包括的なアプローチは、より多くの人々が複雑な生殖の課題を克服し、以前には不可能だった方法で家族形成の選択肢を広げるのに役立っています。

リプロダクティブ・ヘルスにおける不妊治療サービスの拡大する応用と革新とは？

不妊治療サービスの応用と革新は、医療技術、遺伝学、個別化された生殖医療における飛躍的な進歩により、急速に拡大しています。不妊治療サービスにおける最も重要な進歩のひとつは、体外受精（IVF）の台頭です。体外受精は、体外で卵子を受精させ、受精卵を子宮に移植する方法です。技術の進歩に伴い、体外受精の成功率は上昇し、不妊症の最も効果的な治療法のひとつとなっています。タイムラプス画像や胚モニタリングシステムなどの技術革新により、胚培養士は胚の発育をより正確に評価できるようになり、着床と妊娠の成功確率が向上しています。

卵子や精子の凍結技術も大幅に改善され、妊孕性温存の機会が増えました。ガラス化を含む凍結保存法により、より高い生存率で卵子や精子を凍結することが可能になり、親になる時期を遅らせる柔軟性を個人に提供しています。これは、化学療法によって妊孕性を失う可能性のあるがん患者や、個人的あるいは仕事上の理由で妊孕性を温存したい女性にとって特に重要です。さらに、精子抽出技術の進歩により、精子の数が少ない男性やその他の生殖能力に問題を抱える男性にも、生殖補助医療技術による妊娠を可能にする解決策が提供されています。

不妊治療サービスにおけるもう一つの画期的な技術革新は、着床前の胚の遺伝子スクリーニングを可能にする着床前遺伝学的検査（PGT）です。PGTは、子宮蓄膿症、鎌状赤血球貧血、ハンチントン病などの染色体異常や遺伝性疾患を検出することができ、体外受精の際に健康な胚のみが移植されることを保証します。この技術は、妊娠成功の可能性を高めるだけでなく、流産や子供の遺伝性疾患のリスクも低減します。遺伝カウンセリングは現在、不妊治療サービスに不可欠な要素となっており、カップルは遺伝的体質に基づいて、生殖の選択肢について十分な情報を得た上で決定することができます。

このような技術的な進歩に加え、不妊治療サービスは、生殖医療に対するより総合的なアプローチへと拡大しています。クリニックは、不妊治療の感情的、身体的、心理的側面に対処することの重要性を認識し、不妊治療コーチング、栄養指導、メンタルヘルスカウンセリング、鍼治療などのサポートサービスを提供するようになってきています。不妊治療クリニックはまた、遠隔医療相談、不妊治療追跡アプリ、遠隔モニタリングが一般的になるなど、デジタルヘルスツールも取り入れています。このような患者中心のケアへのシフトは、複雑な不妊治療の旅を、より大きなサポートと利便性でナビゲートするのに役立っています。

不妊治療サービスにおけるイノベーションのもう一つの分野は、不妊治療における人工知能（AI）と機械学習の利用の拡大です。AIを搭載したシステムは、患者情報、胚の発育、治療結果などの大規模なデータセットの分析に利用されており、医師が不妊治療計画についてより正確な判断を下すのに役立っています。例えば、AIは、患者の病歴、遺伝学、胚の質に基づいて体外受精サイクルの成功率を予測するために使用することができ、よりパーソナライズされた効果的な治療戦略を可能にします。こうした技術革新により、不妊治療はより効率的で、利用しやすく、成功しやすくなり、家庭を築こうとする個人やカップルに新たな可能性をもたらしています。

不妊治療サービス市場の成長を促進する要因とは？

不妊治療サービス市場の成長には、不妊症の有病率の上昇、出産の遅れ、生殖技術の進歩、不妊治療に対する社会的受容の高まりなど、いくつかの重要な要因があります。主な促進要因のひとつは、世界の不妊症の増加であり、これは男女ともに影響を及ぼしています。ライフスタイルの変化、環境汚染物質、ストレス、肥満や多嚢胞性卵巣症候群（PCOS）のような病状などの要因が、不妊率の上昇に寄与しています。自然妊娠の難しさに直面する人が増えるにつれ、体外受精、IUI、妊孕性温存などの治療が一般的になり、不妊治療サービスの需要は増加の一途をたどっています。

不妊治療サービス市場の成長に寄与するもう一つの重要な要因は、出産の遅れの動向です。キャリア、教育、個人的な目標を優先する女性が増える中、多くの女性が人生の後半に子どもを持つことを選択しています。しかし、特に女性にとっては、年齢とともに生殖能力が低下するため、年齢が不妊の重大な要因となっています。卵子凍結や体外受精を含む不妊治療サービスは、生殖能力を維持し、人生の後半に妊娠することを望む女性に解決策を提供し、これらのサービスに対する需要の増加につながっています。さらに、再婚や混合家族の増加に伴い、不妊治療サービスは高齢の個人や一緒に子供を持ちたいと願うカップルに利用されており、市場の成長をさらに促進しています。

生殖技術の進歩も不妊治療サービス市場の拡大に重要な役割を果たしています。着床前遺伝学的検査（PGT）、タイムラプス胚イメージング、凍結保存技術などの革新的治療により、不妊治療の成功率が向上し、生殖補助を求める個人やカップルにとってより魅力的なものとなっています。不妊治療クリニックにおけるAIと機械学習の統合は、より個別化されたケアを提供し、治療戦略を最適化することによって、治療結果をさらに向上させています。こうした技術の進歩は、不妊治療をより効果的で身近なものにし、より多くの人々が不妊治療の選択肢を模索することを促しています。

不妊治療に対する社会的受容の高まりも、市場成長を促す大きな要因です。かつてはタブー視され、汚名を着せられていた不妊治療も、現在では特に先進国で広く受け入れられ、受け入れられています。公人や有名人が不妊治療についてオープンに語ることで、不妊に対する偏見が薄れ、より多くの人々が不妊治療を受けるようになっています。さらに、同性婚の承認、代理出産やドナープログラムの利用可能性など、法的・社会的な進歩は、LGBTQ+の個人やひとり親が家族を築くための新たな道を提供しています。このような治療がより身近になり常態化するにつれて、不妊治療サービス市場は拡大を続けています。

不妊治療に対する政府の支援やヘルスケア適用の拡大も市場の成長を後押ししています。多くの国では、保険会社やヘルスケアシステムが体外受精のような不妊治療に関連する費用の一部を負担し始めており、より多くの人々にとってより手の届きやすいものとなっています。リプロダクティブ・ヘルスを推進し、不妊治療に対する経済的支援を提供する政府の取り組みも、こうしたサービスへのアクセスを増やす一助となっています。出生率が低下している地域では、政府が人口増加を促進する国家的取り組みの一環として不妊治療に投資しており、市場の拡大にさらに貢献しています。

結論として、不妊症を克服したり、親になる時期を遅らせたり、非伝統的な家族形成の選択肢を追求したりするために生殖補助医療を求める個人やカップルが増えるにつれて、不妊治療サービス市場は大きく成長する態勢を整えています。生殖技術の進歩、社会的受容の拡大、不妊治療サービスへのアクセスの増加により、この業界は、人々の子宝の夢の実現を支援する上で、さらに大きな役割を果たすことになるでしょう。不妊治療が進化・改善し続けるにつれ、より包括的で効果的な、個人に合った治療が提供され、世界中の生殖医療と家族計画の状況に革命をもたらすと思われます。

調査対象企業の例（注目の44社）

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP11932

Global Fertility Services Market to Reach US$124.2 Billion by 2030

The global market for Fertility Services estimated at US$47.0 Billion in the year 2023, is expected to reach US$124.2 Billion by 2030, growing at a CAGR of 14.9% over the analysis period 2023-2030. Fresh Non-Donor Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of the analysis period. Growth in the Frozen Non-Donor Services segment is estimated at 13.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.1 Billion While China is Forecast to Grow at 19.3% CAGR

The Fertility Services market in the U.S. is estimated at US$12.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.7 Billion by the year 2030 trailing a CAGR of 19.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

Global Fertility Services Market - Key Trends and Drivers Summarized

How Are Fertility Services Revolutionizing Reproductive Health and Family Planning?

Fertility services are transforming reproductive health and family planning by offering advanced medical interventions and personalized care to individuals and couples facing challenges in conceiving. With increasing awareness and acceptance of fertility treatments, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), egg freezing, and genetic screening, are giving hope to millions of people worldwide. Fertility services include a range of treatments that help diagnose and treat infertility, support family planning, and improve reproductive health. These services are becoming essential in the modern landscape of healthcare, allowing individuals and couples to realize their dreams of parenthood despite age, medical conditions, or other factors.

In recent years, the demand for fertility services has grown due to societal changes, such as delayed childbearing, lifestyle factors, and rising infertility rates. Fertility clinics now offer a wide array of services, from fertility assessments and hormonal treatments to cutting-edge ART procedures. The rise of egg freezing, particularly among women who wish to preserve their fertility for future pregnancies, has become a significant trend. This expansion of fertility services is not only empowering individuals to take control of their reproductive health but is also making family planning more accessible and inclusive, especially for same-sex couples, single parents, and those facing reproductive health challenges. As fertility treatments advance and societal acceptance grows, these services are playing a transformative role in how people plan their families.

Why Are Fertility Services Critical for Addressing Reproductive Challenges and Expanding Family Planning Options?

Fertility services are critical for addressing reproductive challenges and expanding family planning options because they offer medical solutions to individuals and couples who may face obstacles in conceiving naturally. With the increasing prevalence of infertility—affecting around 10-15% of couples globally—fertility services provide hope and support by diagnosing and treating underlying conditions that hinder conception. Whether due to age, hormonal imbalances, genetic factors, or lifestyle issues, infertility can be emotionally and physically taxing. Fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation enable people to overcome these barriers and achieve successful pregnancies.

Fertility services are also crucial in providing options for those who may not face infertility but are seeking alternatives for family planning. Women who choose to delay childbearing for personal or career reasons can now turn to egg freezing, which preserves their eggs at an optimal time, giving them the flexibility to conceive later in life. Additionally, fertility services offer crucial options for LGBTQ+ individuals and couples, as well as single parents, who may require donor eggs, sperm, or surrogacy to start a family. These services ensure that parenthood is not limited by biological constraints or traditional family structures, offering more inclusive and diverse pathways to having children.

Another key role of fertility services is in addressing medical conditions like polycystic ovary syndrome (PCOS), endometriosis, and male infertility issues such as low sperm count or motility. These conditions often go undiagnosed and untreated, but fertility clinics provide targeted treatments and interventions that increase the chances of conception. Furthermore, advancements in genetic screening and preimplantation genetic testing (PGT) allow for the identification of genetic disorders before pregnancy, ensuring healthier outcomes for both parents and babies. This comprehensive approach to fertility care is helping more people navigate complex reproductive challenges and expand their family-building options in ways that were not possible before.

What Are the Expanding Applications and Innovations in Fertility Services Across Reproductive Health?

The applications and innovations in fertility services are rapidly expanding, driven by breakthroughs in medical technology, genetics, and personalized reproductive care. One of the most significant advancements in fertility services is the rise of in vitro fertilization (IVF), which has revolutionized how couples and individuals approach infertility. IVF involves the fertilization of an egg outside the body, followed by the implantation of the embryo into the uterus. As technology improves, success rates for IVF have increased, making it one of the most effective treatments for infertility. Innovations such as time-lapse imaging and embryo monitoring systems allow embryologists to assess the development of embryos with greater precision, improving the chances of successful implantation and pregnancy.

Egg and sperm freezing technologies have also seen significant improvements, providing more opportunities for fertility preservation. Cryopreservation methods, including vitrification, have made it possible to freeze eggs and sperm with higher survival rates, offering individuals the flexibility to delay parenthood. This is particularly important for cancer patients who may face fertility loss due to chemotherapy, as well as women who want to preserve their fertility for personal or professional reasons. Additionally, advancements in sperm extraction techniques have provided solutions for men with low sperm counts or other fertility issues, allowing them to conceive through assisted reproductive technologies.

Another groundbreaking innovation in fertility services is preimplantation genetic testing (PGT), which allows for the genetic screening of embryos before implantation. PGT can detect chromosomal abnormalities or genetic disorders such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, ensuring that only healthy embryos are transferred during IVF. This technology not only increases the chances of a successful pregnancy but also reduces the risk of miscarriage and genetic diseases in the child. Genetic counseling is now an integral part of fertility services, allowing couples to make informed decisions about their reproductive options based on their genetic makeup.

In addition to these technological advancements, fertility services are expanding to include a more holistic approach to reproductive health. Clinics are increasingly offering support services such as fertility coaching, nutritional guidance, mental health counseling, and acupuncture, recognizing the importance of addressing the emotional, physical, and psychological aspects of fertility treatment. Fertility clinics are also embracing digital health tools, with telemedicine consultations, fertility tracking apps, and remote monitoring becoming more common. This shift toward patient-centered care is helping individuals navigate the complex fertility journey with greater support and convenience.

Another area of innovation in fertility services is the growing use of artificial intelligence (AI) and machine learning in fertility treatments. AI-powered systems are being used to analyze large datasets of patient information, embryo development, and treatment outcomes, helping doctors make more accurate decisions about fertility treatment plans. For example, AI can be used to predict the success rates of IVF cycles based on patient history, genetics, and embryo quality, allowing for more personalized and effective treatment strategies. These innovations are making fertility treatments more efficient, accessible, and successful, opening up new possibilities for individuals and couples seeking to build families.

What Factors Are Driving the Growth of the Fertility Services Market?

Several key factors are driving the growth of the fertility services market, including the rising prevalence of infertility, delayed childbearing, advancements in reproductive technologies, and increasing societal acceptance of fertility treatments. One of the primary drivers is the growing global incidence of infertility, which is affecting both men and women. Factors such as lifestyle changes, environmental pollutants, stress, and medical conditions like obesity and polycystic ovary syndrome (PCOS) are contributing to rising infertility rates. As more people face challenges in conceiving naturally, the demand for fertility services continues to rise, with treatments like IVF, IUI, and fertility preservation becoming more commonplace.

Another significant factor contributing to the growth of the fertility services market is the trend toward delayed childbearing. With more women prioritizing their careers, education, and personal goals, many are choosing to have children later in life. However, age is a critical factor in fertility, particularly for women, as fertility declines with age. Fertility services, including egg freezing and IVF, provide solutions for women who wish to preserve their fertility and conceive later in life, leading to increased demand for these services. Additionally, with the rise in second marriages and blended families, fertility services are being used by older individuals or couples who wish to have children together, further driving market growth.

Advancements in reproductive technologies are also playing a crucial role in the expansion of the fertility services market. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and cryopreservation techniques have improved the success rates of fertility treatments, making them more appealing to individuals and couples seeking reproductive assistance. The integration of AI and machine learning in fertility clinics is further enhancing treatment outcomes by providing more personalized care and optimizing treatment strategies. These technological advancements are making fertility treatments more effective and accessible, encouraging more people to explore fertility options.

The growing societal acceptance of fertility treatments is another major factor driving market growth. Fertility treatments, once considered taboo or stigmatized, are now widely accepted and embraced, especially in developed countries. Public figures and celebrities openly discussing their fertility journeys have helped to reduce the stigma around infertility, encouraging more people to seek fertility services. Moreover, legal and social advancements, such as the recognition of same-sex marriages and the availability of surrogacy and donor programs, are providing new pathways for LGBTQ+ individuals and single parents to build families. As these treatments become more accessible and normalized, the fertility services market continues to expand.

Increasing government support and healthcare coverage for fertility treatments are also driving the growth of the market. In many countries, insurance companies and healthcare systems are beginning to cover a portion of the costs associated with fertility treatments like IVF, making them more affordable for a broader population. Government initiatives that promote reproductive health and provide financial assistance for fertility treatments are also helping to increase access to these services. In regions where fertility rates are declining, governments are investing in fertility treatments as part of national efforts to boost population growth, further contributing to the expansion of the market.

In conclusion, the fertility services market is poised for significant growth as more individuals and couples seek reproductive assistance to overcome infertility, delay parenthood, or pursue non-traditional family-building options. With advancements in reproductive technologies, growing societal acceptance, and increasing access to fertility services, the industry is set to play an even larger role in helping people realize their dreams of parenthood. As fertility treatments continue to evolve and improve, they will provide more inclusive, effective, and personalized care, revolutionizing the landscape of reproductive health and family planning worldwide.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Fertility Services - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Infertility Rates Driving Demand for Fertility Services
    • Advancements in Assisted Reproductive Technologies (ART) Enhancing Success Rates
    • Growing Acceptance and Legalization of IVF and Surrogacy Across Different Regions
    • Market Trends Toward Personalized Treatment Plans Based on Genetic Testing
    • Future Directions: Integration of AI and Machine Learning in Fertility Treatment Protocols
    • Technological Innovations in Embryo Screening and Preservation Techniques
    • Global Increase in Same-Sex Couples and Single Parents Using Fertility Services
    • Regulatory and Ethical Considerations in Egg and Sperm Donation
    • Development of Mobile Apps and Online Platforms for Fertility Consultation and Management
    • Market Response to Growing Trends in Egg Freezing for Career Planning
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Services Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Egg & Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinical Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • INDIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • AFRICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION